Obstetrics & Gynaecology: Conference papers Collection home page

Browse
Subscribe to this collection to receive daily e-mail notification of new additions RSS Feed RSS Feed RSS Feed
Collection's Items (Sorted by Submit Date in Descending order): 741 to 760 of 1501
TitleAuthor(s)Issue Date
 
A new strategy of antenatal diagnosis of homozygous a-thalassaemia-1
Proceeding/Conference:Hospital Authority Convention, HAC 1997
1997
 
First trimester ultrasound prediction of pregnancies affected by homozygous alpha-thalassaemia-1
Proceeding/Conference:Proceedings of the 3rd World Congress of Perinatal Medicine
1996
 
Second trimester hydrops fetalis in pregnancies affected by homozygous alpha-thalassaemia-1
Proceeding/Conference:Proceedings of the 6th World Congress on Ultrasound in Obstetrics and Gynaecology
1996
 
1997
 
Biochemical screening for Downs syndrome - Hong Kong experience
Proceeding/Conference:Proceedings of the 2nd Asian Congress on Down Syndrome Screening
1997
 
2012
 
Symptom clusters in cancer survivors in Hong Kong - a cluster analysis
Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2012
2012
1998
Continuing professional development - A surrogate for recertification?
Proceeding/Conference:Annals of the Academy of Medicine Singapore
2004
 
2012
 
The upregulation of miR-141 confers anoikis resistance through targeting KLF12 in ovarian cancer cells
Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2012
2012
 
miR-141 confers anoikis resistance of ovarian cancer cells by targeting KLF12
Proceeding/Conference:Research Postgraduate Symposium, RPS 2012
2012
 
Increased activation of TAK1/NFkB activity is associated with the aggressiveness of ovarian cancers
Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2012
2012
 
2012
 
2012
 
2012
 
Bitter melon extract (BME) used as natural AMPK activator in inhibiting ovarian cancer cells growth
Proceeding/Conference:CSH Asia / ICMS 2012 Joint Conference on Tumor Microenvironment
2012
 
Bitter Melon Extract (BME) used as natural AMPK activator in inhibiting ovarian cancer cells growth
Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2012
2012
 
The prognostic and therapeutic potential of AMP-activated protein kinase in ovarian cancer
Proceeding/Conference:International Workshop on Gynecologic Oncology, ASGO 2012
2012
 
The AMP-activated protein kinase gamma-2 (AMPK-γ2) subunit acts as a modifier of AMPK activity in ovarian cancer cells
Proceeding/Conference:CSH Asia / ICMS 2012 Joint Conference on Tumor Microenvironment
2012
Collection's Items (Sorted by Submit Date in Descending order): 741 to 760 of 1501